基于库马林的衍生物的抗癌机制
Anand Kumar Yadav1, Ramina Maharjan Shrestha1, Paras Nath Yadav1
1Central Department of Chemistry, Tribhuvan University, Kathmandu, Nepal.
European journal of medicinal chemistry
|February 10, 2024
概括
库马林通过抑制癌细胞增殖,血管新生和转移,显示出显著的抗瘤潜力. 这些天然化合物及其合成衍生物为各种癌症类型提供选择性,强大的抗癌机制.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 库马林是一种在自然界中发现和合成的化合物,具有多样化的生物活动.
- 癌症的特点是无法控制的细胞生长,需要新的治疗药物.
- 以前的研究表明,氨酸具有具有高选择性的有希望的抗瘤特性.
研究的目的:
- 审查过去十年中合成和分离的库马林的抗癌机制.
- 突出库马林衍生物对抗癌症所采用的各种治疗策略.
主要方法:
- 对氨酸合成,分离和体外抗癌评估研究的文献综述.
- 分析报告的机制,包括抑制血管生成,微管不稳定,诱导亡和酶抑制.
主要成果:
- 异丁氧氨酸通过降低化学激素水平来抑制血管生成.
- 素C会破坏微管的稳定,显示出抗增殖和抗转移的作用.
- 各种库马林衍生物通过不同的信号通路 (例如PI3K/Akt/mTOR) 诱导亡,并抑制诸如芳酶等关键酶.
结论:
- 库马林是开发新型抗癌药物的多功能支架.
- 它们的多方面的作用机制,包括向血管生成,微管和特定的信号通路,强调了它们的治疗潜力.
- 对库马林衍生物的进一步研究可能会导致更有效和更有选择性的癌症治疗.
更多相关视频
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


